The business stories that matter, by Fortune's Colin Barr
Type Size  -  +
February 25, 2008, 10:47 pm

Pfizer pulls Lipitor ads

Pfizer (PFE) pulled a series of commercials in which a well-known scientist touted its cholesterol-busting drug Lipitor. The spots featured Dr. Robert Jarvik, who came to fame in the 1980s after inventing an artificial heart. His inventing prowess aside, it turns out Jarvik isn’t a licensed heart doctor - a fact that led some members of Congress to criticize the Pfizer ads. “It seems that Pfizer’s No. 1 priority is to sell lots of Lipitor, by whatever means necessary, including misleading the American people,” U.S. Rep. John Dingell said.

In response, the New York-based drugmaker said Monday it would pull the ads and seek “greater clarity in our advertising regarding the presentation of spokespeople.” The decision is a big one for the company: The New York Times reports Pfizer spent $258 million between January 2006 and September 2007 on the Jarvik campaign, as cheaper generic drugs threatened to make inroads into Lipitor’s lucrative market.

Jarvik’s qualifications to discuss heart medicine weren’t the only questionable aspect of the ads. A story in the Times earlier this month noted that one spot that appeared to depict Jarvik rowing was actually shot using an actor. “He’s about as much an outdoorsman as Woody Allen,” a colleague said of Jarvik. And about as much of a cholesterol expert, it now seems.

CNNMoney.com Comment Policy: CNNMoney.com encourages you to add a comment to this discussion. You may not post any unlawful, threatening, libelous, defamatory, obscene, pornographic or other material that would violate the law. Please note that CNNMoney.com may edit comments for clarity or to keep out questionable or off-topic material. All comments should be relevant to the post and remain respectful of other authors and commenters. By submitting your comment, you hereby give CNNMoney.com the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying information via all forms of media now known or hereafter devised, worldwide, in perpetuity. CNNMoney.com Privacy Statement.
Colin Barr covers business and finance for Fortune.com. Previously he was an editor at TheStreet.com and author of the weekly Five Dumbest Things on Wall Street column, and an editor at Dow Jones Newswires.
Subscribe to Daily Briefing: RSS feed | email newsletter
* : Time reflects local markets trading time.† - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges.• Disclaimer
Powered by WordPress.com.